Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K = 0.81 µM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K = 4.1 µM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
Sub-micromolar inhibition of SARS-CoV-2 3CLpro by natural compounds
Bruno Rizzuti
Primo
;
2021
Abstract
Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K = 0.81 µM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K = 4.1 µM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.| File | Dimensione | Formato | |
|---|---|---|---|
|
Rizzuti et al., Pharmaceuticals 2021;14,892-1-10.pdf
accesso aperto
Descrizione: Rizzuti et al., Pharmaceuticals 2021;14,892-1-10
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.92 MB
Formato
Adobe PDF
|
1.92 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


